Build a research bookmark that preserves original sources
Use the prompt in Lesson 3 to make a bookmark for one research project, with separate links for the trial registration, company disclosure, and findings from human studies.
BodyCoding Case Calendar
Explore research, body education, and hands-on AI projects by date. Every case links to a source and a point to verify.
Research
Body Education
Agent Projects
November 2026
MonTueWedThuFriSatSun
Cases this month
15 casesExplore a health report built with synthetic data
Apple Health Analyst uses generated data in a public demo with date ranges, metric summaries, and charts covering longer periods.
What does a consumer DNA test report cover?
MedlinePlus Genetics explains how to interpret consumer genetic test results and how test coverage and other context shape their interpretation.
Read SURMOUNT‑1 for follow-up duration and the control group
This 2022 Phase 3 trial compared tirzepatide with placebo in adults with overweight or obesity without diabetes and reported weight outcomes at 72 weeks.
See how Lian Kuai uses Codex to log workouts
The creator represents each strength-training set as a selectable block. The demo data shows how to select entries, replay a workout set by set, and compare two sessions.
Why is it hard to explain complex traits with one gene?
MedlinePlus Genetics uses heart disease, type 2 diabetes, and obesity to show how multiple genes and the environment shape common health outcomes.
What was the primary endpoint in SELECT?
Published in 2023, this randomized trial enrolled adults with overweight or obesity and established cardiovascular disease without diabetes. Its primary endpoint covered major cardiovascular events.
Can you guess which group has the higher average after splitting the data?
Switch between pooled and grouped views of a fictional dataset. The two markers have different overall averages and the same averages within each batch.
How did Fractyl document its development decision?
In its October 22, 2026 disclosure, Fractyl said it would stop internal development of its Rejuva gene therapy program and explore other options.
Read a GLP‑1 drug labeling update
On November 9, 2026, the U.S. FDA announced required GLP‑1 receptor agonist labeling changes concerning the potential risk of NAION, a rare optic nerve disorder.
What did the early CTX310 study measure?
On November 9, 2026, CRISPR Therapeutics announced Phase 1b results for CTX310, reporting changes in blood lipid measures among participants with severe hypertriglyceridemia.
Build a one-page follow-up summary from eight sample records
This demo sorts fictional follow-up records by date and puts weights, notes, and questions for a clinician on one printable page.
Read STEP 1 as a randomized controlled trial
This 2021 double-blind study compared weight outcomes with semaglutide and placebo in adults with overweight or obesity without diabetes over 68 weeks.
What does genome editing change?
The National Human Genome Research Institute explains genome editing and why researchers study the relationship between DNA changes and traits.
How are GLP‑1 and GLP‑1 receptor agonists related?
The World Health Organization explains the role of the body's GLP‑1 signal and how related medicines mimic it.